Thu, Apr 17, 2014, 1:52 AM EDT - U.S. Markets open in 7 hrs 38 mins


% | $
Quotes you view appear here for quick access.

Brainstorm Cell Therapeutics Inc. Message Board

  • jhamreturns jhamreturns Mar 15, 2013 5:53 AM Flag

    10K is out

    end of message...until I have a chance to look at it.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • How about this from page 32 (credit to "Underachieved" on I-cell for catching this - notice "The Company does not expect to generate revenues from operations until 2013" part):


      Results of Operations

      The Company has been a development stage company since its inception. For the period from inception (September 22, 2000) until December 31, 2012, the Company did not generate any revenues from operations. The Company does not expect to generate revenues from operations until 2013. In addition, the Company incurred operating costs and expenses of approximately $3,518,000 during the year ending December 31, 2012, and approximately $44,940,000 for the period from inception (September 22, 2000) through December 31, 2012. Operating expenses incurred since inception were approximately $18,751,000 for general and administrative expenses and $26,189,000 for research and development costs.


      Sentiment: Buy

    • Did you see the Europe disclosure in there? I hadn't heard that yet......

      In January 2013, the European Medicine Agency (“EMA”) Committee for Advanced Therapies, classified NurOwn as an Advanced Therapy Medicinal Product.

      In January 2013, we also submitted an application for Orphan Medicinal Product Designation for our NurOwn cell product to the EMA. A reply is expected in May 2013.

      Sentiment: Buy

0.2506+0.0001(+0.04%)Apr 16 3:54 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.